27. DIRECTORS’ EMOLUMENTS AND INTERESTS IN THE COMPANY
 
Emoluments paid to the directors and prescribed officers of the Company by the Company and its subsidiaries for the year to 30 September, are set out below:
2020 2019
Executive directors – shareholding Direct Indirect3 Associate
interest 		Direct Indirect2 Associate
interest
Executive directors
PG Wharton-Hood¹ 300 000 862 706  – – – –
PP van der Westhuizen2 241 636 350 000  4 832 164 746 – 4 832
Past executive director
SB Viranna4 n/a  170 515 224 731 –
541 636 1 212 706  4 832 335 261 224 731 4 832

Executive directors – total remuneration earned Salaries
R’000		   Bonus and
performance-
related
payments
R’000 		  Performance-
related
accrual
relating to
current year
R’000 		  CEO acting  
allowance  
and bonus5
R’000  		   Other
allowances
R’000		   Gains on  
long-term  
incentive  
scheme6
R’000  		   Medical aid
contributions
R’000		   Pension fund
contribution
R’000		   Total
remuneration
R’000		  
2020                                    
Executive directors                                    
PG Wharton-Hood1 641   –   –    –      10    –      –    27    678  
PP van der Westhuizen 5 333   1 853   3 394   –     146   776     6   226   11 734  
PP van der Westhuizen5 –   –   –   2 425     –   –     –   –   2 425  
Past executive director                                    
SB Viranna4 3 083   –   –   –     31   2 805     5   129   6 053  
  9 057   1 853   3 394   2 425     187   3 581     11   382   21 234  
2019                                    
Executive directors                                    
SB Viranna4 5 887   2 624   4 462   –     33   3 038     32   247   16 323  
PP van der Westhuizen 4 084   2 352   2 311   –     95   460     37   174   9 513  
  9 971   4 976   6 773   –     128   3 498     69   421   25 836  
1 PG Wharton-Hood was appointed as Chief Executive Officer on 1 September 2020.
2 PP van der Westhuizen purchased 58 500 shares on 20 November 2020, increasing his direct shareholding to 300 136. PP van der Westhuizen was granted 600 shares on 2 December 2020, increasing his indirect shareholding to 350 600. Refer note 19.
3 The indirect beneficial shareholding is subject to vesting conditions. Refer note 19.
4 SB Viranna resigned as Chief Executive Officer with effect from 17 January 2020. Leave payout amounted to R14 000.
5 PP van der Westhuizen in his capacity as acting Chief Executive Officer from 18 January 2020 to 31 August 2020.
6 Relates to notional shares. Shares were only purchased on vesting.

  Awards received during 2020  
Long-term incentive scheme Number
of shares		   Date of
issue		   Issue price
R/share		  
PG Wharton-Hood            
2020 allocation1 862 706   82 590   21.97  
  Dividends   Closing balance at
30 September 2020		  
Long-term incentive scheme Value
of dividends
in respect
of all plans
(R)		   Number
of shares		   Final
vesting
date		  
PG Wharton-Hood            
2020 allocation1 –   862 706   Dec 25  
  Opening
balance at
1 October
2019		   Awards received during 2020  
Long-term incentive scheme Number
of shares		   Number
of shares		   Date of
issue		   Issue price
R/share		  
PP van der Westhuizen                
2020 allocation¹ –   350 000   Sep 20   17.11  
  Dividends   Closing balance at
30 September 2020		  
Long-term incentive scheme Value
of dividends
in respect
of all plans
(R)		   Number
of shares		   Final
vesting
date		  
PP van der Westhuizen            
2020 allocation1 –   350 000   Dec 25  
1 Refer note 19.

  Total shareholding shares   Directors’ fees R’000  
  2020   2019   2020   2019  
Non-Executive directors                
MA Brey1 4 300 349   4 900 349   1 136   1 175  
PJ Golesworthy2 31 224   31 224   1 061   1 080  
ME Jacobs –   –   591   507  
VL Litlhakanyane³ –   –   221   –  
AM Mothupi –   –   667   664  
JK Netshitenzhe –   –   501   421  
MP Ngatane –   –   572   493  
M Sello –   –   397   421  
GC Solomon 2 143 612   143 612   729   810  
RT Vice –   –   712   826  
  4 475 185   5 075 185   6 587   6 397  
1 MA Brey’s direct beneficial shareholding is 716 370 (2019: 716 370), his indirect beneficial shareholding is 3 484 787 (2019: 4 084 787) and his associate interest is 99 192 (2019: 99 192).
2 PJ Golesworthy and GC Solomon’s total shareholding only includes direct beneficial shares.
3 VL Litlhakanyane was appointed as non-executive director on 15 April 2020.

The directors’ fees are paid by a subsidiary company of Life Healthcare Group Holdings Limited.

Prescribed officers

In line with the requirements of the Companies Act, the Group discloses the remuneration paid to prescribed officers who are defined as the Chief Executive Officer, the Chief Financial Officer, Chief Executive Officer – southern Africa and Chief Executive Officer – International.

  Total
shareholding		   Salaries
R’000		   Bonus
and per- formance-related
payments
R’000		   Performance-related
accrual
relating
to current
year
R’000		   Other
allowances
R’000		   Gains on
long-term
incentive
scheme
R’000		   Medical
aid
contributions
R’000		   Pension
fund
contributions
R’000		   Total
remuneration
R’000		  
2020                                    
PG Wharton-Hood                                    
PP van der Westhuizen Refer emoluments disclosed under executive directors  
AM Pyle 82 590   3 331   1 273   2 012   18   405   6   151   7 196  
MD Chapman 185 787   5 535   –   2 854   259   –   –   569   9 217  
2019                                    
SB Viranna                                    
PP van der Westhuizen Refer emoluments disclosed under executive directors  
AM Pyle –   3 374   1 469   2 357   151   –   37   142   7 530  
MD Chapman4 –   1 681   –   1 232   61   –   –   168   3 142  
4 MD Chapman was appointed as a prescribed officer from 1 June 2019.

Total shareholding for AM Pyle and MD Chapman is subject to vesting conditions. Refer note 19.

  Awards received during 2020  
Long-term incentive scheme Number
of shares		   Issue price
R/share		  
AM Pyle        
2020 allocation1 82 590   21.97  
  Dividends   Closing balance at
30 September 2020		  
Long-term incentive scheme Value
of dividends
in respect
of all plans
(R)		   Number
of shares		   Final
vesting
date		  
AM Pyle            
2020 allocation1 n/a   82 590   31 Mar 2021  
  Opening balance at
1 October 2019		   Awards received
during 2020		  
Long-term incentive scheme Number
of shares		   Issue price
R/share		   Number
of shares		   Issue price
R/share		  
MD Chapman                
2020 allocation1 –   –   185 787   21.97  
C convertible shares 10 000   n/a   –   –  
  Dividends   Closing balance at
30 September 2020		  
Long-term incentive scheme Value
of dividends
in respect
of all plans
(R)		   Number
of shares		   Final
vesting
date		  
MD Chapman            
2020 allocation1 n/a   185 787   30 Sep 2021  
C convertible shares n/a   10 000   30 Sep 2021  
1 Refer note 19.

No director or prescribed officer has a notice period of more than six months. No director’s service contract includes predetermined compensation as a result of termination that would exceed one year’s salary and benefits.